Market Overview:

The global Gene Editing Industry Growth is expected to undergo solid growth over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR). The global gene editing market is mainly driven by the growing demand for gene editing tools from the biotechnology sector, where gene editing is becoming an increasingly important tool for research of various kinds. The growing gene editing market is profiled in detail in the report with the help of detailed information about the market’s historical growth trajectory. This information provides solid backing for the projections presented in the report for the market’s likely growth trajectory from 2017 to 2023.

Gene editing has become a vital tool in the biotechnology sector due to the ability it provides to enhance the natural capabilities of an organism and make it more powerful and more resistant to certain factors. The growing demand for genetically modified wheat and other plants is likely to be a major driver for the gene editing market over the forecast period. Food security in several leading economies, such as India and China, is dependent on genetically modified crops, which ensure a larger yield and better resistance to pests. The larger yield provided by these strains has become vital for these countries, despite concerns about raising a monoculture and the adverse effects of the same on the biodiversity of crops in these regions. This is likely to result in steady growth of the gene editing market, as genetically modified crops are an important commodity for a number of countries around the world.

Competitive Analysis:

• Transposagen Biopharmaceuticals Inc
• Thermo Fisher Scientific Inc
• Sigma-Aldrich Corporation
• Sangamo Biosciences Inc
• OriGene Technologies Inc
• New England Biolabs Inc
• Lonza Group Ltd
• Integrated DNA Technologies Inc

Segmentation:

• The global gene editing market is segmented on the basis of method, application, end use, and region.
• By method, the global gene editing market is segmented into CRISPR, TALEN, ZFN, antisense technology, and others. CRISPR holds by far the largest share in the global gene editing market, followed by TALEN. Further enhancements in CRISPR technology to make it even more precise and useful are likely to further increase the share of the segment in the coming years.
• By application, the global gene editing market is segmented into plant genetic engineering, animal genetic engineering, microorganism genetic engineering, and gene therapy.

By end use, the global gene editing market is segmented into the biotech industry, the pharmaceutical industry, and contract research organizations.

Regional Analysis:

The Americas market is the dominant revenue generator in the global gene editing market, followed by Europe. This duopoly is likely to remain strong in the coming years, despite strong growth of the market in Asia Pacific.